EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Diagnostic Potential of Urine CXCL10 and Donor-Derived cfDNA in Kidney Transplant Rejection

Daniel Fantus, Robert Balshaw, Chee Loong Saw, Majda Belkaid, Narin S Tangprasertchai, Thierry Viard, François Gougeon, Justin Belair, Claude Daniel, Caroline Lamarche, Sílvia Casas, Heloise Cardinal und 1 weitere

Transplant International · 27.03.2026 · 39

DOI: 10.3389/ti.2026.15517 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Transplant International, online erschienen am 27.03.2026. Verfasst von Daniel Fantus und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection, Chemokine CXCL10, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Data suggests donor-derived cell-free DNA (dd-cfDNA) and urine CXCL10 outperform serum creatinine as a biomarker of antibody-mediated rejection (AMR) and T cell-mediated rejection (TCMR). We hypothesized that combining these biomarkers would improve the overall detection of rejection. We performed a retrospective two-center, case-controlled study of 103 adult renal transplant recipients who had for-cause or surveillance biopsies with corresponding urine and plasma samples. Rejection was classified by Banff 2022 criteria. While log 10 %dd-cfDNA correlated more strongly than log 10 CXCL10 with glomerulitis (r = 0.55, p < 0.001 vs. r = 0.25, p = 0.01) and peritubular capillaritis (r = 0.47, p < 0.001 vs. r = 0.23, p = 0.02), log 10 CXCL10 was a better correlate of tubulitis (r = 0.28, p = 0.004 vs. r = 0.054, p = 0.59). Both dd-cfDNA > 0.5% (OR 21.9, 95% CI 3.74–180, p < 0.001) and de novo DSA (OR 10.4, 95% CI 1.16–157, p = 0.037) were independently associated with AMR vs. no rejection (NR), while log 10 serum creatinine and log 10 CXCL10 were not (p > 0.05). While dd-cfDNA >0.5% (OR 5.37, 95% CI 1.04–31.5, p = 0.047) was independently associated with Banff ≥1A TCMR vs. NR, log 10 CXCL10 was a significant predictor of TCMR in a model without %dd-cfDNA (OR 3.12, 95% CI 1.09–10.4, p = 0.043). Biomarker-guided screening strategies based on dd-cfDNA and urine chemokines such as CXCL10 for AMR (microvascular injury) and TCMR (tubulitis) warrant further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationGraft RejectionChemokine CXCL10Cell-Free Nucleic AcidsHumansFemaleMaleMiddle AgedBiomarkersRetrospective StudiesAdultCase-Control StudiesCreatinineTissue DonorsBiopsy

Stichwörter der Autor:innen

CXCL10dd-cfDNAkidney transplantationnon-invasive immune monitoringrejection

Substanzen

Chemokine CXCL10Cell-Free Nucleic AcidsBiomarkersCXCL10 protein, humanCreatinine

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.
  • Centre de Recherche de CHUM (CRCHUM), Montreal, QC, Canada.
  • George and Fay Yee Centre for Healthcare Innovation, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
  • Histocompatiblility and Immunogenetics Laboratory, McGill University Health Center (MUHC), Montreal, QC, Canada.
  • CareDx Inc., Brisbane, CA, United States.
  • Department of Pathology and Cell Biology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.

Zitieren

APA

Fantus, D., Balshaw, R., Saw, C. L., Belkaid, M., Tangprasertchai, N. S., Viard, T., Gougeon, F., Belair, J., Daniel, C., Lamarche, C., Casas, S., Cardinal, H., & Ho, J. (2026). Diagnostic Potential of Urine CXCL10 and Donor-Derived cfDNA in Kidney Transplant Rejection. Transplant International, 39. https://doi.org/10.3389/ti.2026.15517

Vancouver

Fantus D, Balshaw R, Saw CL, Belkaid M, Tangprasertchai NS, Viard T, et al. Diagnostic Potential of Urine CXCL10 and Donor-Derived cfDNA in Kidney Transplant Rejection. Transplant International. 2026;39. doi:10.3389/ti.2026.15517

BibTeX
@article{Fantus2026,
  author = {Fantus, Daniel and Balshaw, Robert and Saw, Chee Loong and Belkaid, Majda and Tangprasertchai, Narin S and Viard, Thierry and Gougeon, François and Belair, Justin and Daniel, Claude and Lamarche, Caroline and Casas, Sílvia and Cardinal, Heloise and Ho, Julie},
  title = {Diagnostic Potential of Urine CXCL10 and Donor-Derived cfDNA in Kidney Transplant Rejection},
  journal = {Transplant International},
  year = {2026},
  volume = {39},
  doi = {10.3389/ti.2026.15517}
}
Kostenlos starten →